The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-hydroxyisoquinolinone ID: ALA5268593
Chembl Id: CHEMBL5268593
Max Phase: Preclinical
Molecular Formula: C9H9NO2
Molecular Weight: 163.18
Associated Items:
Names and Identifiers Canonical SMILES: O=C1NCCc2c(O)cccc21
Standard InChI: InChI=1S/C9H9NO2/c11-8-3-1-2-7-6(8)4-5-10-9(7)12/h1-3,11H,4-5H2,(H,10,12)
Standard InChI Key: CMNQIVHHHBBVSC-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 163.18Molecular Weight (Monoisotopic): 163.0633AlogP: 0.68#Rotatable Bonds: ┄Polar Surface Area: 49.33Molecular Species: NEUTRALHBA: 2HBD: 2#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.65CX Basic pKa: ┄CX LogP: 0.78CX LogD: 0.76Aromatic Rings: 1Heavy Atoms: 12QED Weighted: 0.59Np Likeness Score: 0.98
References 1. Zhao Y, Zhang LX, Jiang T, Long J, Ma ZY, Lu AP, Cheng Y, Cao DS.. (2020) The ups and downs of Poly(ADP-ribose) Polymerase-1 inhibitors in cancer therapy-Current progress and future direction., 203 [PMID:32717529 ] [10.1016/j.ejmech.2020.112570 ]